Work

Safety and biological activity of the FLT3 inhibitor lestaurtinib in infant MLL-rearranged (MLL-r) ALL: Children's Oncology Group protocol AALL0631.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.9548

Authors: Di Sun, Allison Kaeding, Daniel Magoon, Tamekia Jones, Meenakshi Devidas, Andrew J Carroll, Nyla A. Heerema, Mignon L. Loh, Elizabeth A. Raetz, Naomi Joan Winick, William L. Carroll, ZoAnn Eckert Dreyer, Stephen Hunger, Joanne M. Hilden, Patrick Andrew Brown

Institutions: Johns Hopkins University, Johns Hopkins Medicine, Children's Oncology Group, University of Alabama at Birmingham, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, University of California, San Francisco, NYU Langone Health, Children's Medical Center, Texas Children's Hospital, University of Colorado Anschutz, University of Colorado Denver, Sidney Kimmel Comprehensive Cancer Center

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2600445928

Cites:

Cited by: 3

Related to: 10